This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Ideaya Biosciences, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Kimberline Yang Gerrick: Innovator in Cancer Treatment
Introduction
Kimberline Yang Gerrick is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Gerrick holds a patent for a combination therapy that includes a methionine adenosyltransferase II alpha (MAT2A) inhibitor and a Type II protein arginine methyltransferase (Type II PRMT) inhibitor. This combination product is designed to treat various cancers, including solid tumors, and is beneficial for addressing MAT2A-associated and/or PRMT-associated diseases. He has 1 patent to his name.
Career Highlights
Gerrick is currently associated with Ideaya Biosciences, Inc., where he continues to work on groundbreaking therapies aimed at improving cancer treatment outcomes. His expertise and dedication to research have positioned him as a valuable asset in the biotechnology sector.
Collaborations
One of his notable coworkers is Claire L Neilan, with whom he collaborates on various projects within the company.
Conclusion
Kimberline Yang Gerrick's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the field of biotechnology. His contributions are paving the way for new therapeutic options for patients facing challenging diseases.